1. AB1091 Tolerability of vaccination of 13 pcv in patients with jia, without systemic manifestations. (12th June 2018) Authors: Alexeeva, E.; Dvoryakovskaya, T.; Soloshenko, M.; Denisova, R.; Isaeva, K.; Mamutova, A.; Mayansky, N.; Tkachenko, N.; Zubkova, I.; Kaluzhnaya, T.; Gayvoronskaya, A.; Broeva, M.; Fedoseenko, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0458 EFFICACY AND SAFETY OF PCV13 VACCINATION IN JIA PATIENTS WITH SYSTEMIC MANIFESTATIONS ON TOCILIZUMAB AND CANAKINUMAB TREATMENT. (2nd June 2020) Authors: Vankova, D.; Alexeeva, E.; Dvoryakovskaya, T.; Isaeva, K.; Chomakhidze, A.; Denisova, R.; Mamutova, A.; Fetisova, A.; Gautier, M.; Krekhova, E.; Shingarova, M.; Kriulin, I.; Kontorovich, A.; Galkina, O.; Radygina, T.; Zubkova, I.; Tkachenko, N.; Orlova, Y.; Kurdup, M.; Ismailova, A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 826 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Natesto™, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. (22nd December 2015) Authors: Rogol, A. D.; Tkachenko, N.; Bryson, N. Journal: Andrology Issue: Volume 4:Number 1(2016:Jan.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗